bonyf Aktie
WKN DE: BONF01 / ISIN: BE6333353298
|
16.04.2024 15:19:57
|
bonyf exhibits at PLMA Amsterdam on 28-29 May 2024
|
bonyf NV
/ Key word(s): Development of Sales/Investment
Dissemination of a Financial Wire News, transmitted by EQS Group. |
| Language: | English |
| Issuer: | bonyf NV |
| Doornzelestraat 114 D | |
| 9000 Gent | |
| Belgium | |
| Phone: | +41 79 412 42 79 |
| E-mail: | president@bonyf.com |
| Internet: | www.bonyf.com |
| ISIN: | BE6333353298 |
| EQS News ID: | 1881789 |
| End of Announcement - EQS News Service | |
|
|
1881789 16-Apr-2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu bonyfmehr Nachrichten
|
15.10.25 |
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream (EQS Group) | |
|
15.09.25 |
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf (EQS Group) | |
|
05.09.25 |
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments (EQS Group) | |
|
11.08.25 |
Periocream: The Future Commercial Winner for bonyf (EQS Group) | |
|
14.07.25 |
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility (EQS Group) | |
|
30.06.25 |
Annual Results 2024 (EQS Group) | |
|
03.06.25 |
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India (EQS Group) | |
|
15.05.25 |
bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy (EQS Group) |
Analysen zu bonyfmehr Analysen
Aktien in diesem Artikel
| bonyf | 12,90 | 22,86% |
|